The iShares Core High Dividend ETF (HDV) relies heavily on energy and pharmaceutical sectors, with Exxon Mobil, Chevron, Johnson & Johnson, and AbbVie making up about 26% of its assets. Exxon and Johnson & Johnson are rated very safe due to strong cash flows and long dividend streaks, while Chevron is safe with improved cash flow and debt reduction. AbbVie is growing but carries more leverage risk. Overall, HDV's income looks stable if oil prices remain steady and AbbVie's product transition succeeds, but risks rise if oil prices fall sharply and leverage issues worsen.
Brent crude oil prices surged above $100 a barrel following US strikes on Iranian tankers, escalating Middle East geopolitical tensions and disrupting global supply. This supply shock benefits upstream energy companies like ConocoPhillips, Exxon Mobi...
ExxonMobil shares have surged 40% year-to-date, reaching $164.83 amid rising oil prices driven by Middle East supply issues. The company's strong earnings, including $14.5 billion in Q2 profits and record production levels, support the rally. However...
Chevron shares have surged over 42% in 2026, approaching a 52-week high near $212. Strong Q2 earnings, production growth, and debt reduction support the rally, but the stock trades above its price target of $204.67, suggesting limited upside. Bulls p...
ExxonMobil reported strong Q2 2026 results with earnings more than doubling and free cash flow reaching $17.2 billion, overcoming challenges from Middle East disruptions. Growth in Guyana and the Permian Basin, along with global trading, helped offse...
ExxonMobil maintains a buy rating due to strong free cash flow, disciplined capital spending, and attractive valuation. In Q2, the company achieved record upstream production, generated $18.9 billion in free cash flow, and returned $5.1 billion to sh...
